{
  "retracted": false,
  "timestamp": 1486598400000,
  "updates": [
    {
      "timestamp": 1495719506945,
      "identifier": {
        "doi": "10.1371/journal.pone.0172184"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1371/journal.pone.0164455"
  },
  "journal": "PLOS ONE",
  "publisher": "Public Library of Science (PLoS)",
  "title": "Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study"
}
